Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Edwards Lifesciences News Editors

News Widget

Display the Edwards Lifesciences news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Edwards Lifesciences News

News on Edwards Lifesciences (Ticker: EW) continually updated from thousands of sources around the net.

13 hrs ago | Freshnews

Edwards Lifesciences to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference

Thomas M. Abate, Edwards Lifesciences' corporate vice president, chief financial officer, is scheduled to speak to conference attendees at 2:40 p.m. PDT.

Comment?

Related Topix: Biotech, Medicine, Medical Equipment, Healthcare Industry, Embrella Cardiovascular, Marketwire, Rancho Palos Verdes, CA

Fri May 18, 2012

AmericanBankingNews.com

Canaccord Genuity Reiterates "Buy" Rating on Edwards Lifesciences

A number of other firms have also recently commented on EW. Analysts at Goldman Sachs raised their price target on shares of Edwards Lifesciences from $90.00 to $97.00 in a research note to investors on Wednesday, May 2nd.

Comment?

Related Topix: Financial Services, Biotech, Embrella Cardiovascular, Medicine, Medical Equipment, Healthcare Industry, Wells Fargo , Banking

Mon May 14, 2012

PR-inside.com

Market Report, "Edwards Lifesciences Corporation - SWOT Analysis", published

Edwards Lifesciences Corporation - SWOT Analysis company profile is the essential source for top-level company data and information.

Comment?

Related Topix: Biotech, Medicine, Medical Equipment, Healthcare Industry, Marketing, Irvine, CA

Thu May 10, 2012

Seeking Alpha

Edwards Lifesciences' CEO Hosts Annual Meeting of Stockholders Conference

Welcome, good morning everyone. This is the 2012 Annual Meeting of Stockholders for Edwards Lifesciences.

Comment?

Related Topix: Biotech, Embrella Cardiovascular, Medicine, Medical Equipment, Healthcare Industry, Corporate Governance, Law

Mon May 07, 2012

Wall St. Cheat Sheet

Equity Insights May 7th: Warner Chilcott, Global Payments, Edwards Lifesciences, NetApp, Solazyme

Warner Chilcott plc : BofA/Merrill is assuming assuming a sale of Warner Chilcott and said if it does not happen there are other alternatives to drive shares higher.

Comment?

Related Topix: Solazyme, Biotech, Startups, Medicine, Warner Chilcott, Financial Services, Global Payments, Medical Equipment, Healthcare Industry, Embrella Cardiovascular

Sun May 06, 2012

Journalgazette.net

Hearts are key to J&J strategy

If you are interested in this story, you might be interested in others from The Journal Gazette.

Comment?

Related Topix: Food, J and J Snack Foods, Fort Wayne, IN, Johnson & Johnson, Medicine, Medical Equipment, Healthcare Industry, St Jude Medical, Biotech, Embrella Cardiovascular

Thu May 03, 2012

Freshnews

Edwards Lifesciences to Webcast Annual Meeting of Stockholders

A live webcast of the meeting will be available to all interested parties on the Edwards Lifesciences' investor relations website at http://www.edwards.com/InvestorRelations/Pages/EventCalendar.aspx . A replay of the webcast can be accessed at this site approximately one hour after the conclusion of the live event and will be available for 30 days ... (more)

Comment?

Related Topix: Biotech, Medicine, Medical Equipment, Healthcare Industry, Embrella Cardiovascular, Marketwire, Irvine, CA

Wed May 02, 2012

Freshnews

New Data on Edwards Intuity Valve System Demonstrate Promise of Rapid Deployment Platform

Edwards Lifesciences Corporation , the global leader in the science of heart valves and hemodynamic monitoring, announced that new data from the European multi-center TRITON trial studying the EDWARDS INTUITY valve system highlights the promise of several important benefits, including the facilitation of small-incision surgery for aortic valve ... (more)

Comment?

Related Topix: Biotech, Medicine, Medical Equipment, Healthcare Industry, Embrella Cardiovascular

AmericanBankingNews.com

Edwards Lifesciences Price Target Raised to $97.00 at Goldman Sachs

The firm currently has a "buy" rating on the stock. The analysts wrote, "Now that the guidelines have been issued, we think the ramp in center opening should accelerate .

Comment?

Related Topix: Financial Services, Biotech, Embrella Cardiovascular, Medicine, Medical Equipment, Healthcare Industry, Wells Fargo , Banking

Seeking Alpha

Edwards Lifesciences ([[EW]] +0.9%) shrugs off this mornings...

Edwards Lifesciences shrugs off this mornings weakness after the Centers for Medicare & Medical Services announced it will cover Transcatheter Aortic Valve Replacement procedures for the treatment of symptomatic aortic valve stenosis, for which EW 's Sapien is a marquee product.

Comment?

Related Topix: Biotech, Embrella Cardiovascular, Medical Equipment, Medicine, Healthcare Industry

Los Angeles Jobs

Also on Topix